Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE), PI of the investigator-initiated BIONETIC-TRA study, joins us to share his rationale behind this study evaluating the safety and feasibility of the Dynetic-35 cobalt chromium balloon-expandable stent system for the treatment of iliac artery lesions via a transradial approach. With growing discussions in Europe surrounding outpatient treatment, it’s crucial to gain more data about this interventional approach. 

Having excellent experiences so far, Dr Lichtenberg details his optimism on the outlook for radial access for peripheral interventions in the future.